Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
3.985
0.00 (0.00%)
Jun 20, 2025, 9:40 AM - Market open
Inozyme Pharma Employees
Inozyme Pharma had 67 employees as of December 31, 2024. The number of employees increased by 8 or 13.56% compared to the previous year.
Employees
67
Change (1Y)
8
Growth (1Y)
13.56%
Revenue / Employee
n/a
Profits / Employee
-$1,592,776
Market Cap
258.69M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 67 | 8 | 13.56% |
Dec 31, 2023 | 59 | 3 | 5.36% |
Dec 31, 2022 | 56 | 6 | 12.00% |
Dec 31, 2021 | 50 | 12 | 31.58% |
Dec 31, 2020 | 38 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
INZY News
- 4 weeks ago - INOZYME PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inozyme Pharma, Inc. - INZY - Business Wire
- 5 weeks ago - BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma - PRNewsWire
- 5 weeks ago - Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 2 months ago - Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency - GlobeNewsWire
- 2 months ago - Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 3 months ago - Inozyme Pharma Reports Full Year 2024 Financial Results and Announces Strategic Prioritization of ENPP1 Deficiency Pivotal Program and Recent Business Highlights - GlobeNewsWire
- 4 months ago - Inozyme Pharma to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 4 months ago - Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025 - GlobeNewsWire